PNNL contributes to a nationwide research consortium investigating the molecular mechanisms triggered by endurance training.

The Rapid Assessment of Platform Technologies to Expedite Response project aims to prepare against future pandemics.

New research findings published in Science Advances (November 2022), help explain the progression of Alzheimer-related dementia in each patient. The findings outline a biological classification system that predicts disease severity.

The scientist behind the online cartoon RedPen/BlackPen explains how humor can build bridges between scientists and the public.

Scientists have devised a way to engineer yeast to produce sustainable, eco-friendly commodity chemicals using computing power as a guide.

The nested nanoPOTS chip is the next generation of technology developed at PNNL to prepare single cells for proteomics.

PNNL data scientists are refining their artificial intelligence tools with COVID-19 data to advance therapeutics and treatments for a future pandemic.

PNNL researchers are forming a clearer picture of how plant matter is transformed in the microbial gardens created by leaf-cutter ants.

PNNL computational biologists, structural biologists, and analytical chemists are using their expertise to safely accelerate the design step of the COVID-19 drug discovery process.

Pacific Northwest National Laboratory (PNNL) researchers pioneer a new tool to represent cellular response to viral infection.

Six months into a pandemic that has claimed more than 570,000 lives worldwide, scores of PNNL scientists are engaged in dozens of projects in the fight against COVID-19.

Accurate identification of metabolites, and other small chemicals, in biological and environmental samples has historically fallen short when using traditional methods.